Table 1.
n | HR (95% CI) | p | |
---|---|---|---|
TVN | 44 | 0.935 (0.878–0.996) | 0.037 |
TVN without haplogroup-specific variants | 44 | 1.076 (0.862–1.344) | 0.515 |
TVN without AV | 44 | 0.918 (0.849–0.992) | 0.031 |
CRVN | 44 | 0.912 (0.830–1.002) | 0.055 |
CRVN without AV | 44 | 0.875 (0.768–0.997) | 0.046 |
HVR1 (C16024-C16569) variant number | 44 | 0.998 (0.807–1.233) | 0.982 |
HVR1 variant number without AV | 44 | 1.002 (0.801–1.254) | 0.983 |
HVR2-3 (C1-C576) variant number | 44 | 0.692 (0.517–0.928) | 0.014 |
HVR2-3 variant number without AV | 44 | 0.704 (0.520–0.953) | 0.023 |
Total AV number | 44 | 0.845 (0.682–1.047) | 0.124 |
HR below 1 indicates favourable DMFS with higher number of mtDNA base variants, from Cox proportional hazard models
AV ancestral variants, C control region, CI confidence interval, CRVN coding region variant number, DMFS distant metastasis-free survival, HR hazard ratio, HVR hypervariable region (the C region’s base sites within the HVRs are given in brackets), TVN total variant number, WB-mtDNA whole blood mitochondrial DNA